key: cord-0689186-ead07dc5
authors: Yin, Wanchao; Mao, Chunyou; Luan, Xiaodong; Shen, Dan-Dan; Shen, Qingya; Su, Haixia; Wang, Xiaoxi; Zhou, Fulai; Zhao, Wenfeng; Gao, Minqi; Chang, Shenghai; Xie, Yuan-Chao; Tian, Guanghui; Jiang, He-Wei; Tao, Sheng-Ce; Shen, Jingshan; Jiang, Yi; Jiang, Hualiang; Xu, Yechun; Zhang, Shuyang; Zhang, Yan; Xu, H. Eric
title: Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
date: 2020-05-01
journal: Science
DOI: 10.1126/science.abc1560
sha: f40631c38739955895a09a0796722e29f1bc5512
doc_id: 689186
cord_uid: ead07dc5

The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a target of the antiviral drug, Remdesivir. Here we report the cryo-EM structure of the SARS-CoV-2 RdRp either in the apo form at 2.8 Å resolution or in complex with a 50-base template-primer RNA and Remdesivir at 2.5 Å resolution. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is covalently incorporated into the primer strand at the first replicated base pair and terminates chain elongation. Our structures provide critical insights into the mechanism of viral RNA replication and a rational template for drug design to combat the viral infection.

The pandemic of Corona Virus Disease 2019 (COVID-19) caused by SARS-CoV-2 has become a global crisis. The replication of SARS-CoV-2 requires the viral RNA-dependent RNA polymerase (RdRp), a target of the antiviral drug, Remdesivir. Here we report the cryo-EM structure of the SARS-CoV-2 RdRp either in the apo form at 2.8 Å resolution or in complex with a 50-base template-primer RNA and Remdesivir at 2.5 Å resolution. The complex structure reveals that the partial double-stranded RNA template is inserted into the central channel of the RdRp where Remdesivir is covalently incorporated into the primer strand at the first replicated base pair and terminates chain elongation. Our structures provide critical insights into the mechanism of viral RNA replication and a rational template for drug design to combat the viral infection. polymerization activity on a poly-U template upon addition of adenosine triphosphate (ATP) (Fig. 1 , B and C). This RNA polymerization activity was effectively inhibited by the addition of the active triphosphate form of Remdesivir (RTP) (Fig.  1D) . Even in the presence of 10 mM ATP, 1 mM RTP completely inhibited RdRp polymerization activity. In contrast, Remdesivir, as a prodrug, at 5 mM concentration, did not have any inhibitory effect on the polymerization activity of the purified enzyme ( fig. S1F ), neither did Remdesivir in its monophosphate form (RMP) (fig. S1G ).

The purified RdRp complex is relatively thermostable with a melting temperature of 53°C ( fig. S1H ). Negative-stain EM visualization of the nsp12-nsp7-nsp8 complex displayed monodispersed particles with excellent homogeneity (fig. S1I). For the apo nsp12-nsp7-nsp8 complex, we vitrified the sample in the presence of the detergent DDM. The initial attempt at image processing revealed that the particles are preferentially oriented ( fig. S2A ). Therefore, we collected over 7,400 micrograph movies of more than 5.7 million particle projections to increase the number of projection from the non-preferential orientation. Of these, 81,494 particles were used to yield a density map of 2.8 Å resolution ( fig. S2 , B and E). Cryo-EM studies of the nsp12-nsp7-nsp8 complex bound with the template-primer RNA and RTP (termed as the template-RTP RdRp complex) faced two challenges ( fig. S3 ). First, most particles were adsorbed to cryo-EM grid bars rather than staying in the vitreous ice. Second, the RNA duplex were dissociated from the template-RTP RdRp complex likely due to conditions of cryo-EM specimen preparation. Eventually, we prepared the cryo-EM specimen of the template-RTP RdRp complex at 15 mg/ml, much higher than normal concentrations used for EM studies of soluble protein complexes. The high concentration of the complex has a mass action effect to stabilize the RNA-protein complex and has excess amount of the complex to escape the absorption of cryo-EM grid bars to enter the vitreous ice ( fig. S3 ). We collected 2,886 micrograph movies, which yielded a 2.5 Å resolution structure using 130,386 particle projections. Because of the relatively high resolution of our structure, the EM map is clear for key structural features across the complex ( fig. S4 , A to F).

The structure of the apo RdRp complex contains one nsp12, one nsp7 and two nsp8, with an overall arrangement resembling those seen in SARS-CoV and the recently solved structure of SARS-CoV-2 (15, 23) (Fig. 2, A and B) . Different from the SARS-CoV RdRp structure but similar to the recent SARS-CoV-2 RdRp structure, our structure reveals that nsp12 also contains an N-terminal β-hairpin (residues 31-50) and an extended nidovirus RdRp-associated nucleotidyl-transferase domain (NiRAN, residues 115-250) (24) , with seven helices and three β-strands (15, 23) . Following the NiRAN domain is an interface domain (residues 251-365) composed of three helices and five β-strands, which is connected to the RdRp domain (residues 366-920) (Figs. 1A and 2B). The nsp12 RdRp domain displays the canonical cupped right-handed configuration (25) , with the finger subdomain (resides 397-581 and residues 621-679) forming a closed circle with the thumb subdomain (residues 819-920) (Fig. 2, A and B) . The closed conformation is stabilized by the binding of nsp7 and nsp8, with one nsp8 molecule sitting on the top of the finger subdomain and interacting with the interface domain. The closed conformation of nsp12 is further stabilized by the nsp7-nsp8 heterodimer, which is packed against the thumb-finger interface (Fig. 2, A and B ). In addition, we were able to assign two zinc ions in the conserved metal binding motifs composed by H295-C301-C306-C310 and C487-H642-C645-C646 (Fig. 2C) , which are also observed in the SARS-CoV RdRp structure (15) . These zinc ions likely serve as conserved structural components in maintaining the integrity of the RdRp architecture.

The structure of the template-RTP RdRp complex contains one nsp12, one nsp7 and one nsp8 (Fig. 3 , A and B). The second nsp8 was largely invisible in the EM map of the template-RTP complex ( fig. S4C ), therefore it was not included in the final model. In addition, the template-RTP RdRp structure contains 14-base RNA in the template strand, 11-base RNA in the primer strand, and the inhibitor Remdesivir in its monophosphate form (RMP) (Fig. 3 , C and D), which is covalently linked to the primer strand, as well as a pyrophosphate and three magnesium ions that may serve as catalytic ions near the active site ( Fig. 3D and fig. S4 , D to F) (26) .

The overall structure of the template-RTP RdRp complex is similar to the apo RdRp structure, with nsp12 in a closed conformation (Figs. 2A and 3A). The double-stranded RNA helix, formed by 11 base-pairs from the template-primer RNA (Figs. 3C and 4, A to E), is held by the finger-palm-thumb subdomains. Extensive protein-RNA interactions are observed between the template-primer RNA and nsp12, with a total of 29 residues from nsp12 directly participating in the binding of the RNA (Fig. 4E) . Surprisingly no RNA interactions are mediated by nsp7 or nsp8 although these two proteins are required for RNA binding by RdRp. Most protein-RNA interactions involve the RNA phosphate-ribose backbones, with many interactions directly to 2′-OH groups (Fig.  4E ), thus providing a basis to distinguish RNA from DNA. There are no contacts from nsp12 to any base pairs of the template-primer RNA, suggesting a sequence independent binding of RNA by RdRp. This is consistent with the fact that no specific sequence is required for the enzymatic activity of RdRp at the elongation step.

At the 3′ end of the primer strand is Remdesivir monophosphate (RMP) (Figs. 3D and 4, D and E, and fig. S4 , E and F), which is covalently incorporated into the primer strand at the +1 position (Fig. 4E) . Additional nucleotides at the +2 and +3 positions of the template strand interact with residues from the back of finger subdomain (Fig. 4, A the presence of excess RTP in complex assembly, only a single RMP is assembled into the primer strand as observed in the structure. Thus, Remdesivir, like many nucleotide analog prodrugs, inhibits the viral RdRp activity through non-obligate RNA chain termination, a mechanism that requires the conversion of the parent drug to the active triphosphate form (27, 28) . The RMP position is at the center of the catalytic active site (Fig. 3D) . As an adenosine monophosphate analog, RMP forms base-stacking interactions with upstream base from the primer strand and two hydrogen bonds with the uridine base from the template strand ( Fig. 3D and fig. S5 ). In addition, RMP also forms interactions with side chains from K545 and R555. Near the bound RMP are two magnesium ions and a pyrophosphate. Both magnesium ions interact with the phosphate diester backbone and they are part of catalytic active site. The pyrophosphate is at the gate of the nucleotide entry channel to the active site and may block the entry of nucleotide triphosphate to the active side (Fig. 3, C and D) .

The catalytic active site of the nsp12 RdRp is constructed by seven conserved motifs from A to G (Figs. 1A and 3E and  fig. S6 ). Motifs ABCD are from the palm subdomain with an SDD sequence (residues 759-761) in motif C forming the catalytic active center (Fig. 3D) . Both D760 and D761 are involved in coordination of the two magnesium ions at the catalytic center. Motifs F and G are located within the finger subdomain and they interact with the template strand RNA and direct this strand into the active site (Fig. 3E) . Motif F also interacts with the primer strand RNA with the side chains of K545 and R555 contacting the +1 base (Fig. 3D) , thus stabilizing the incoming nucleotide in the correct position for catalysis. The orientation of template-primer RNA in the active site is similar to the orientation of template-primer RNA in the poliovirus RdRp elongation complex (29) and the HCV NS5B RdRp inhibitor complex (30) (fig. S7 ). The residues involved in RNA binding as well as residues comprising the catalytic active site are highly conserved (31, 32), highlighting the conserved mechanism of genome replication by RdRp in these diverse RNA viruses, and suggesting it may be possible to develop broad spectrum antiviral inhibitors such as Remdesivir (18) and Galidesivir (BCX4430) (33) .

Structural comparison reveals several interesting differences between the apo and complex structures (Fig. 3, E and  F, and fig. S8, A and B) . First, nsp7 moves toward the RdRp core by 1.5 Å (as measured by nsp7 residue F49, fig. S8, A and  B ), leading to a rearrangement of the interface, which results in weaker association of the second nsp8 in the complex. Second, the loop that connects the first and second helix of the thumb subdomain moves outward by 2.8 Å (as measured by nsp12 residue I847) to accommodate the binding of the double stranded RNA helix (Fig. 3F) . Third, motif G residues K500 and S501 also move outward by 2.0 Å to accommodate the binding of the template strand RNA. Outside of these changes, the apo nsp12 and the RNA-complex nsp12 are very similar, with an RMSD of 0.52 Å for all Cα atoms across the whole protein. In particular, the structural elements that make up the catalytic active site can be exactly superimposed (Fig. 3E) , suggesting that the SARS-CoV-2 RdRp is a relatively stable enzyme that is ready to function as a replicase upon binding of RNA template. Viral RdRp is a highly processive enzyme with a rate of replication up to 100 nucleotides per second (34) . No significant conformational changes between the apo and the active enzyme structures are consistent with the high processivity of the viral RNA polymerase, which does not need to consume additional energy for conformational changes in the active site during the replication cycle.

Besides Remdesivir, several nucleotide analog drugs, including Favipiravir, Ribavirin, Galidesivir, and EIDD-2801, efficiently inhibit SARS-CoV-2 replication in cell-based assays (35, 36) . Like Remdesivir, these nucleotide analogs are proposed to inhibit the viral RdRp through non-obligate RNA chain termination, a mechanism that requires the conversion of the parent compound to the triphosphate active form (33) . The structure of the template-RTP RdRp complex provides an excellent model to rationalize how these drugs inhibit the SARS-CoV-2 RdRp activity ( fig. S8C ). In particular, EIDD-2801 has been shown to be 3-10 times more potent than Remdesivir in blocking SARS-CoV-2 replication (36) . The N4 hydroxyl group off the cytidine ring forms an extra hydrogen bond with the side chain of K545 and cytidine base also forms an extra hydrogen bond with the guanine base from the template strand. These two extra hydrogen bonds may explain the apparent higher potency of EIDD-2801 in inhibiting SARS-CoV-2 replication.

The COVID-19 pandemic has inflicted emotional pain and economic burden across the globe. Enzymes that are vital for the viral life cycle are excellent antiviral drug targets as they are different from the host proteins. Among viral enzymes, RdRp is the major target of many existing nucleotide drugs. In this paper, we report the structure of the SARS-CoV-2 RdRp complex in the apo form and in the complex with a template-primer RNA and the active form of Remdesivir. The structures reveal how the template-primer RNA is recognized by the enzyme and how chain elongation is inhibited by Remdesivir. Structure comparison and sequence alignment suggest that the mode of substrate RNA recognition and Remdesivir inhibition of RdRp is highly conserved in diverse RNA viruses, providing a basis for designing broad spectrum antiviral drugs based on nucleotide analogs. Moreover, our structures provide a solid template for modeling and modifying the existing nucleotide drugs, including the highly potent EIDD-2801. Together, these observations provide a rational basis to design even more potent inhibitors to combat the vicious infection of SARS-CoV-2. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material. 

Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group

An interactive web-based dashboard to track COVID-19 in real time

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins

Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structural basis of receptor recognition by SARS-CoV-2

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

The coronavirus replicase

Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates

The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent

One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Washington State 2019-nCoV Case Investigation Team, First Case of 2019 Novel Coronavirus in the United States

Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses

Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer

Structural genomics of the severe acute respiratory syndrome coronavirus: Nuclear magnetic resonance structure of the protein nsP7

NMR Structure of the SARS-CoV Nonstructural Protein 7 in Solution at pH 6.5

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses

RNA synthetic mechanisms employed by diverse families of RNA viruses

SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase

Medline 31. A. J. te Velthuis, Common and unique features of viral RNA-dependent polymerases

Insights from Structure, Function and Evolution

Protection against filovirus diseases by a novel broadspectrum nucleoside analogue BCX4430

Structurefunction relationships underlying the replication fidelity of viral RNA-dependent RNA polymerases

Potential therapeutic agents against COVID-19: What we know so far

An orally bioavailable broadspectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

MotionCor2: Anisotropic correction of beam-induced motion for improved cryoelectron microscopy

Gctf: Real-time CTF determination and correction

RELION: Implementation of a Bayesian approach to cryo-EM structure determination

cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination

Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs

UCSF Chimera-A visualization system for exploratory research and analysis

Coot: Model-building tools for molecular graphics

The Phenix software for automated determination of macromolecular structures

Abscisic acid signaling: Thermal stability shift assays as tool to analyze hormone perception and signal transduction

OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins